In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
March 8th, 2009 | 38 | Yes |
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 4.47 | 10.31 | -47.21 | 2 | 8 | 1 | 76 | 523.698 | 10 | ↓ |
Hi High (pH 8-9.5) | 4.47 | 7.99 | -18.74 | 1 | 8 | 0 | 74 | 522.69 | 10 | ↓ |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
OPRD-1-E | Delta Opioid Receptor (cluster #1 Of 3), Eukaryotic | Eukaryotes | 320 | 0.24 | Binding ≤ 10μM |
OPRK-1-E | Kappa Opioid Receptor (cluster #1 Of 6), Eukaryotic | Eukaryotes | 44 | 0.27 | Binding ≤ 10μM |
OPRM-1-E | Mu-type Opioid Receptor (cluster #1 Of 4), Eukaryotic | Eukaryotes | 16 | 0.29 | Binding ≤ 10μM |
OPRX-1-E | Nociceptin Receptor (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2 | 0.32 | Binding ≤ 10μM |
OPRX-1-E | Nociceptin Receptor (cluster #1 Of 1), Eukaryotic | Eukaryotes | 17 | 0.29 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
OPRD_HUMAN | P41143 | Delta Opioid Receptor, Human | 320 | 0.24 | Binding ≤ 1μM |
OPRK_CAVPO | P41144 | Kappa Opioid Receptor, Guinea Pig | 44 | 0.27 | Binding ≤ 1μM |
OPRM_HUMAN | P35372 | Mu Opioid Receptor, Human | 16 | 0.29 | Binding ≤ 1μM |
OPRX_HUMAN | P41146 | Nociceptin Receptor, Human | 2 | 0.32 | Binding ≤ 1μM |
OPRD_HUMAN | P41143 | Delta Opioid Receptor, Human | 320 | 0.24 | Binding ≤ 10μM |
OPRK_CAVPO | P41144 | Kappa Opioid Receptor, Guinea Pig | 44 | 0.27 | Binding ≤ 10μM |
OPRM_HUMAN | P35372 | Mu Opioid Receptor, Human | 16 | 0.29 | Binding ≤ 10μM |
OPRX_HUMAN | P41146 | Nociceptin Receptor, Human | 2 | 0.32 | Binding ≤ 10μM |
OPRX_HUMAN | P41146 | Nociceptin Receptor, Human | 17 | 0.29 | Functional ≤ 10μM |
Description | Species |
---|---|
G alpha (i) signalling events | |
G-protein activation | |
Opioid Signalling | |
Peptide ligand-binding receptors |